Identification of high platelet reactivity under P2Y12 ADP-receptor blockade: Observation of two platelet populations using the VASP flow cytometric assay and improvement of detection by atypical PFA-P2Y shape of curve

被引：0
|
作者：
Emmanuelle, Scala [1 ]
Javier, Gomez Francisco [1 ]
Carlo, Marcucci [1 ]
Lorenzo, Alberio [1 ]
机构：
[1] Lausanne Univ Hosp CHUV, Lausanne, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2019年 / 149卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1078
引用
收藏
页码：31S / 32S
页数：2
相关论文
共 49 条
  • [31] Effects of pharmacological inhibition of the P2Y1 and P2Y12 ADP receptors on shear-induced platelet aggregation and platelet thrombus formation on a collagen-coated surface under flow conditions
    Cattaneo, M
    Savage, B
    Ruggeri, ZM
    DRUG DEVELOPMENT RESEARCH, 2002, 56 (04) : 565 - 565
  • [32] Crucial role of the ADP receptor P2Y1 in platelet adhesion and signaling under high flow.
    Mazzucato, M
    Cozzi, MR
    Pradella, P
    Ruggeri, ZM
    De Marco, L
    BLOOD, 2002, 100 (11) : 50A - 50A
  • [33] Comparison of P2Y12-receptor blockade in cardiovascular disease patients undergoing antiplatelet therapy by Innovance PFA P2Y assay and light transmission aggregometry using ADP agonist
    Margetic, S.
    Getaldic, B.
    Vuga, I
    Vrkic, N.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1188 - 1189
  • [34] Effects of pharmacological inhibition of the P2Y1 and P2Y12 ADP receptors on shear-induced platelet aggregation and platelet thrombus formation on a collagen-coated surface under flow conditions.
    Cattaneo, M
    Savage, B
    Ruggeri, ZM
    BLOOD, 2001, 98 (11) : 239A - 240A
  • [35] Efficacy of Change to New P2Y12 Receptor Antagonists in Patients High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention
    Robledo-Nolasco, Rogelio
    Godinez-Montes de Oca, A.
    Zaballa-Contreras, J. F.
    Suarez-Cuenca, J. A.
    Mondragon-Teran, P.
    Rubio-Guerra, A. F.
    Melendez-Alcantara, M. A.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2015, 21 (07) : 619 - 625
  • [36] Factors associated with the failure of clopidogrel dose-adjustment according to platelet reactivity monitoring to optimize P2Y12-ADP receptor blockade
    Bonello, Laurent
    Camoin-Jau, Laurence
    Mancini, Julien
    Bessereau, Jacques
    Grosdidier, Charlotte
    Alessi, Marie-Christine
    Ostorero, Michel
    Dignat-George, Francoise
    Paganelli, Franck
    THROMBOSIS RESEARCH, 2012, 130 (01) : 70 - 74
  • [37] ASSESSING ADEQUATE P2Y12 PLATELET INHIBITION BY THE ACCUMETRICS VERIFYNOW ASSAY USING "PLATELET REACTIVITY UNITS" OR "PERCENT INHIBITION": FINDINGS FROM A REAL WORLD REGISTRY
    Muhlestein, J. Brent
    May, Heidi T.
    Lappe, Donald L.
    Bennett, Sterling T.
    Whisenant, Brian K.
    Anderson, Jeffrey L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1254 - E1254
  • [38] The optimal threshold of high post-treatment platelet reactivity could be defined by a point-of-care VerifyNow P2Y12 assay
    Jeong, Young-Hoon
    Kim, In-Suk
    Choi, Bong-Ryong
    Kwak, Choong Hwan
    Hwang, Jin-Yong
    EUROPEAN HEART JOURNAL, 2008, 29 (17) : 2186 - 2187
  • [39] Functional significance of the ADP receptor (P2Y12) in platelet activation initiated by the binding of von Willebrand factor to platelet GP Ibα induced by high shear rates.
    Goto, S
    Tamura, N
    Yoshida, M
    Ikeda, Y
    Handa, S
    CIRCULATION, 2001, 104 (17) : 38 - 38
  • [40] 'A threshold of platelet reactivity for ischaemic events?' and 'The optimal threshold of high post-treatment platelet reactivity could be defined by a point-of care VerifyNow P2Y12 assay': reply
    Price, Matthew J.
    EUROPEAN HEART JOURNAL, 2008, 29 (17) : 2187 - 2187
12345